Nektar Therapeutics
NKTR
#5662
Rank
C$1.63 B
Marketcap
C$80.49
Share price
0.98%
Change (1 day)
273.82%
Change (1 year)

Revenue for Nektar Therapeutics (NKTR)

Revenue in 2025 (TTM): C$88.53 Million

According to Nektar Therapeutics 's latest financial reports the company's current revenue (TTM ) is C$87.34 Million. In 2024 the company made a revenue of C$0.14 Billion an increase over the revenue in the year 2023 that were of C$0.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Nektar Therapeutics from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$88.53 M-37.31%
2024 C$0.14 B18.16%
2023 C$0.11 B-4.31%
2022 C$0.12 B-3.82%
2021 C$0.12 B-33.39%
2020 C$0.19 B30.25%
2019 C$0.14 B-90.79%
2018 C$1.62 B320.18%
2017 C$0.38 B74.01%
2016 C$0.22 B-30.55%
2015 C$0.32 B37.45%
2014 C$0.23 B46.93%
2013 C$0.15 B96.35%
2012 C$80.73 M11.04%
2011 C$72.7 M-54.26%
2010 C$0.15 B110.05%
2009 C$75.68 M-30.98%
2008 C$0.10 B-59.74%
2007 C$0.27 B7.45%
2006 C$0.25 B72.42%
2005 C$0.14 B7.12%
2004 C$0.13 B-0.43%
2003 C$0.13 B-7.99%
2002 C$0.14 B21.38%
2001 C$0.12 B59.55%
2000 C$77.35 M29.6%
1999 C$59.68 M77.97%
1998 C$33.53 M44.45%
1997 C$23.21 M145.65%
1996 C$9.45 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
C$50.18 B 57,361.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$87.60 B 100,197.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$89.62 B 102,511.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
C$0.29 B 235.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$81.10 B 92,754.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
C$15.37 B 17,508.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
C$2.12 B 2,330.25%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
C$128.56 B 147,102.88%๐Ÿ‡บ๐Ÿ‡ธ USA